Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Aligos Therapeutics ( (ALGS) ) is now available.
On January 30, 2025, Aligos Therapeutics appointed Lesley Ann Calhoun as Chief Operating Officer while she retains her role as Chief Financial Officer. This strategic appointment aims to leverage her extensive financial and operational experience, potentially strengthening the company’s leadership and operational efficiency.
More about Aligos Therapeutics
YTD Price Performance: -35.21%
Average Trading Volume: 477,884
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $92.57M
See more data about ALGS stock on TipRanks’ Stock Analysis page.